SecBot SecBot
SECBOTREPLAY Home › Report › XENE

XENE · Director Gary Patou filed a Form 144 notice of intent to sell 1,322…

Xenon Pharmaceuticals Inc. · 144 filed Jun 5, 2026 at 16:32 ET

At the news

NEUTRALIMPACT 2/10

144 filed Jun 5, 2026 at 16:32 ET

Director Gary Patou filed a Form 144 notice of intent to sell 1,322 shares of Xenon Pharmaceuticals common stock, valued at approximately $70,053 based on the filing date. This is a very small sale relative to the company's $5.1B market cap and appears to be a routine, low-conviction signal.

  • Director Gary Patou filed Form 144 to sell 1,322 shares of XENE common stock.
  • Estimated sale value is approximately $70,053 based on the filing date.
  • The shares were acquired from restricted stock units vesting on 05/31/2026.
  • The sale represents a tiny fraction of the company's $5.1B market cap.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access